Bio-Rad Labs (BIO) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $275.60 -0.94%
EPS Growth %: -30.8%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
WF, CWBC, GLTO, More
EPS Growth %: -30.8%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.97, $0.19 better than the analyst estimate of $0.78. Revenue for the quarter came in at $506.1 million versus the consensus estimate of $494.85 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- ResMed (RMD) Tops Q3 EPS by 20c
- USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
